Navigation Links
The Quantum Group Announces Strategic Technology Alliance
Date:2/26/2008

Partners with Net.Orange to provide industry-wide solution

WELLINGTON, Fla., Feb. 26 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) today announced a multi-dimensional, six year alliance established by Quantum wholly-owned subsidiary Quantum Medical Technologies, Inc. with Texas-based Net.Orange, Inc., inventor of the revolutionary cOS(TM) (Clinical Operating System) and many general and therapeutic-specific technology solutions.

The partnership with Net.Orange will bring tested and proven technology processes to the healthcare industry, beginning with the Quantum network of healthcare providers, patients and payers. Additionally, with this new development, the Company further capitalizes on the technology-based provisional business process patents it filed earlier this year.

Pete Martinez, Senior Vice President and Chief Technology and Innovations Officer of The Quantum Group commented, "This is an unprecedented alliance in healthcare. By combining an existing network of more than 1,800 providers with the state-of-the-art business processes, web-based technologies and tools, we will provide real-time value to healthcare services and adoption of the technology. Providers will no longer struggle to identify which technology solutions are right for them, to integrate complex systems in their office or pay for unique pieces of an endless puzzle. We will integrate solutions seamlessly into one patient-centric web-based system. We are bringing the business of healthcare into the 21st century."

Dr. Vasu Rangadass, CEO of Net.Orange stated, "This collaboration is a solution provider's dream. Our relationship with Quantum provides an instant and large base of users anxious for the quality of healthcare improvements we provide. Pairing our innovations in usability, connectivity, and process management with Quantum's providers allows us to deliver an effective springboard for providers to accomplish their ultimate goals of treating more patients, more effectively, at more efficient costs."

Noel J. Guillama, President & CEO of The Quantum Group added, "This alliance brings immediate and exponential value to the healthcare industry. It will empower our patients with information, enable our providers with higher efficiencies, set our payer partners apart through documentable quality of care and extend the science of healthcare through the tremendous knowledge base aggregated by this system. We are a Company driven by innovations and this partnership significantly contributes to the comprehensive platform we have outlined in our business model. Our Board of Directors approved the Company expenditure of $1 million this year to roll out this initiative. Our goal is to raise the bar industry-wide to achieve a new standard in the quality of patient care."

About The Quantum Group, Inc.

The Quantum Group is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services that will be leveraged by leading-edge technology to the nation's largest and fastest growing industry- healthcare.

The Company is engaged in the development and execution of a series of innovative patent-pending technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of over 1,800 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

About Net.Orange, Inc.

Net.Orange(TM) simplifies an increasingly complex healthcare system through robust solutions that are designed to be visually-intuitive, rapidly deployed, and managed with ease. Net.Orange's innovative cOS(TM) (Clinical Operating System) solutions empower all constituents of the healthcare industry by leveraging an extraordinary suite of web-based applications and connectors to existing systems. The company is committed to the objective of helping customers provide superior quality patient care through better decision making and improved productivity. Net.Orange is headquartered in Irving, Texas. For more information, visit http://www.ndorange.com.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

BPC Financial Marketing

John Baldissera

800.368.1217

Or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
2. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
3. The Quantum Group, Inc. Announces Separation of Units
4. Results promising for computational quantum chemical methods for drug development
5. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
6. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
7. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
8. Quantum light beams good for fast technology
9. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
10. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
11. Justice Department Requires Divestiture in UnitedHealth Groups Acquisition of Sierra Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: